静脉血栓栓塞患者隐匿性癌症风险预测评分开发
本研究基于RIETE注册队列的巢式病例对照研究,纳入5,863例VTE患者,旨在开发并验证隐匿性癌症风险评分。444例(7.6%;95%CI,6.8%-8.2%)诊断为隐匿性癌症,多变量分析选出男性、年龄>70岁、慢性肺病、贫血、血小板升高、既往VTE和近期手术等变量构建评分。评分≤2分者癌症比例为5.8%(241/4,150),≥3分者为12%(203/1,713)。结论为首个识别VTE患者隐匿性癌症风险增高的评分,需外部验证。
要点
- VTE患者中隐匿性癌症发生率为7.6%(95%CI 6.8%-8.2%)
- 风险评分变量包括男性、年龄>70岁、慢性肺病、贫血、血小板升高、既往VTE和近期手术
- 评分≥3分者隐匿性癌症比例(12%)高于≤2分者(5.8%)
核心结论
- 开发了首个识别VTE患者隐匿性癌症风险增高的风险评分,需外部验证。
研究设计与样本
- 基于RIETE注册队列(2001-2014年)的巢式病例对照研究,纳入5,863例VTE患者。
- 病例为VTE后30天至24个月内诊断的癌症,对照为同期无癌症的VTE患者。
主要发现
- 5,863例 eligible 患者中444例(7.6%;95%CI,6.8%-8.2%)诊断为隐匿性癌症。
- 多变量分析选出男性、年龄>70岁、慢性肺病、贫血、血小板升高、既往VTE和近期手术等变量构建评分。
- 评分≤2分者癌症比例为5.8%(241/4,150),≥3分者为12%(203/1,713)。
- 内部效度通过bootstrap分析确认,并识别了按性别和年龄亚组的评分。
关键数值与推荐
- 风险评分变量:男性、年龄>70岁、慢性肺病、贫血、血小板升高、既往VTE、近期手术。
临床怎么用
- 该评分可用于识别VTE患者中隐匿性癌症风险增高者,但需外部验证后应用于临床。
局限性
- 研究为巢式病例对照设计,评分需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The benefits of a diagnostic workup for occult cancer in patients with VTE are controversial. Our aim was to provide and validate a risk score for occult cancer in patients with VTE. METHODS: We designed a nested case-control study in a cohort of patients with VTE included in the RIETE (Registro Informatizado Enfermedad TromboEmbólica) registry from 2001 to 2014. Cases included cancer detected beyond the first 30 days and up to 24 months after VTE. Control subjects were defined as patients with VTE with no cancer in the same period. RESULTS: Of 5,863 eligible patients, 444 (7.6%; 95% CI, 6.8%-8.2%) were diagnosed with occult cancer. On multivariable analysis, variables selected were male sex, age > 70 years, chronic lung disease, anemia, elevated platelet count, prior VTE, and recent surgery. We built a risk score assigning points to each variable. Internal validity was confirmed using bootstrap analysis. The proportion of patients with cancer who scored ≤ 2 points was 5.8% (241 of 4,150) and that proportion in those who scored ≥ 3 points was 12% (203 of 1,713). We also identified scores divided by sex and age subgroups. CONCLUSIONS: This is the first risk score that has identified patients with VTE who are at increased risk for occult cancer. Our score needs to be externally validated.
引用
- Jara-Palomares L, Otero R, Jimenez D, et al. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE. Chest. 2016. PMID: 27815153. doi:10.1016/j.chest.2016.10.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。